Rhythm Pharmaceuticals Inc (RYTM)
39.17
-0.43
(-1.09%)
USD |
NASDAQ |
May 16, 16:00
39.16
-0.01
(-0.03%)
After-Hours: 20:00
Rhythm Pharmaceuticals Cash from Investing (Quarterly): 30.05M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 30.05M |
| December 31, 2023 | 22.64M |
| September 30, 2023 | -94.96M |
| June 30, 2023 | 48.19M |
| March 31, 2023 | 18.46M |
| December 31, 2022 | -40.78M |
| September 30, 2022 | -39.70M |
| June 30, 2022 | 35.98M |
| March 31, 2022 | 72.52M |
| December 31, 2021 | 7.248M |
| September 30, 2021 | 62.78M |
| June 30, 2021 | 13.52M |
| March 31, 2021 | -145.71M |
| December 31, 2020 | 61.89M |
| September 30, 2020 | 34.91M |
| Date | Value |
|---|---|
| June 30, 2020 | 32.86M |
| March 31, 2020 | 28.87M |
| December 31, 2019 | -139.13M |
| September 30, 2019 | 41.47M |
| June 30, 2019 | 46.14M |
| March 31, 2019 | 23.54M |
| December 31, 2018 | 12.28M |
| September 30, 2018 | -136.47M |
| June 30, 2018 | 16.44M |
| March 31, 2018 | 20.61M |
| December 31, 2017 | -111.45M |
| September 30, 2017 | 6.443M |
| June 30, 2017 | 2.983M |
| March 31, 2017 | -8.019M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-145.71M
Minimum
Mar 2021
72.52M
Maximum
Mar 2022
4.864M
Average
29.46M
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc | 1.732B |
| Amicus Therapeutics Inc | 7.537M |
| Insmed Inc | 295.32M |
| Altimmune Inc | -39.52M |
| Regeneron Pharmaceuticals Inc | -1.687B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.74M |
| Cash from Financing (Quarterly) | 4.243M |
| Free Cash Flow | -140.47M |
| Free Cash Flow Per Share (Quarterly) | -0.6774 |
| Free Cash Flow to Equity (Quarterly) | -40.74M |
| Free Cash Flow to Firm (Quarterly) | -39.03M |
| Free Cash Flow Yield | -6.13% |